JORDAN JULIE (Chief Medical Officer) received a stock award from NEUROGENE INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/28/2025ACC: 0001404644-25-000021
Officer· Chief Medical Officer
Since Feb 2026
+58.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
58.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.40K
Price / share
—
Trade value
—
% of position
New position
3/26/2025
0.00→8.40K
Total
Net shares
+8.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2025 | A · Award | +8.40K | — | — | New position | 0.00 | 8.40K |
| Total | +8.40K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
50.30K shares
Shares
+50.30K
Strike price
16.14
Held after
50.30K
Exercisable
—
3/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock50.30K shares | 3/26/2025 | A · Award | +50.30K | 16.14 | — | 50.30K |